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ABSTRACT
Introduction: Self-efficacy has been found to
have a direct relation with self-care in diabetes.
Several tools have been developed and used for
evaluating self-efficacy of diabetic patients, the
mostwidelyusedbeing theDiabetesManagement
Self-EfficacyScale (DMSES).Theaimof thepresent
study was to translate, culturally adapt, and
validate the Greek DMSES (GR-DMSES) in order
for it to be used in the ATTICA pilot study of the
SmartCare EU-funded project.
Methods: Using standard procedures, the
original version of DMSES was translated and
culturally adapted into Greek. Content validity
was assessed by an expert panel with the
calculation of a content validity index of the
overall scale. A convenient sample was recruited
to complete the questionnaire. Psychometric
testing of the produced instrument included
internal consistency test (Cronbach’s alpha),
construct validity (factor analysis), and stability
(intraclass correlation coefficient).
Results: One hundred and sixteen patients,
aged 36–86 years, with type 2 diabetes (T2D)
participated in the study. There were no items
excluded from the original scale after the
content validity procedure. The coefficient
Cronbach’s alpha for the internal consistency
was 0.93 and the intraclass correlation
coefficient for the stability with a 5-week time
interval was 0.87 (P\0.001). Factor analysis
yielded four factors related to diet, medical
therapy, medication and feet check, and
physical activity.
Conclusion: The findings supported that the
GR-DMSES was reliable and valid in measuring
self-efficacy related to diabetes self-management,
thus providing a quick and easy-to-use tool for
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INTRODUCTION
Diabetes mellitus (DM) is among the 10 leading
causes of death globally, according to World
Health Organization (WHO) data [1]. The
prevalence of DM for adults was estimated to
be 6.4% in 2010 and is projected to rise to 7.7%
by the year 2030 [2]. European data published
in 2013, show an 8.5% prevalence of diabetes in
the age group of 20–79 years [3]. Consisting an
emerging pandemic, diabetes imposes a large
economic burden on the individual, the
national healthcare system, and the economy
[4]. This is not the consequence of just diabetes
per se, but also of its complications, which
additionally contribute to premature mortality
rates, and social and economic burdens [5].
In order to prevent diabetes, manage existing
diabetes, andprevent or at least slowdown the rate
ofdevelopmentofdiabetescomplications,medical
nutrition therapy (MNT) is recommended [6].
MNT consists of healthy eating, regular physical
activity, and often pharmacotherapy [7]. These
behavioral changes need to be achieved and
maintained, given the fact that diabetes is a
chronic condition, in order to improve clinical
outcomes, health status, and quality of life [8]. In
recognition of diabetes being a largely
self-managed condition, care for those people is
focused on diabetes self-management education
and support, and aims at facilitating the
aforementioned behavior changes [7, 8].
However, behavioral changes are complex
processes that are influenced by various factors,
among which self-efficacy has been identified as a
core one [9].
Self-efficacy is a concept introduced by
Bandura within the context of social learning
theory, which was progressed into the social
cognitive theory [10–12]. Social cognitive
theory postulates that an individual’s behavior
is determined by personal, behavioral, and
environmental factors [10–12]. These factors
are not of equal strength, do not occur
simultaneously and the interaction between
them differs based on the individual, the
particular behavior being examined, and the
specific situation in which the behavior occurs
[12]. However, humans contribute to their own
motivation, behavior, and development due to
five capabilities: symbolizing, vicarious,
forethought, self-regulatory, self-reflective [11,
12]. Self-efficacy is a major determinant of
self-regulation and is defined as ‘‘people’s
beliefs about their capabilities to produce
designated levels of performance that exercise
influence over events that affect their lives’’ [13].
In diabetes, self-efficacy has been found to
have a direct relationwith self-care, in a way that
this construct owns the predictability power of
self-care behavior [14]. This finding has also been
replicated in low-income diabetic populations,
where higher self-efficacy has been associated
with improved glycemic control, medication
adherence, self-care behavior, and mental
health-related quality of life [15]. However,
even though self-efficacy has been found to
positively affect adherence to treatment, mixed
results have been presented regarding the impact
on clinical outcomes [16–18]. This may be partly
attributed to the fact that there is not only one
tool available for assessing self-efficacy.
In fact, several tools have been developed
and used for evaluating self-efficacy of diabetic
patients, the most widely used being the
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Diabetes Management Self-Efficacy Scale
(DMSES) [19]. This tool was originally
developed in 1999 and consists of 20 items that
reflect the tasks a person with type 2 diabetes
(T2D) has to carry out in the context ofmanaging
this condition [20]. These diabetes self-care
activities can be grouped as follows [21]:
1. Performing activities essential for the
treatment of diabetes (i.e., use of
medication, dietary adherence);
2. Self-observation (i.e., of body weight, feet
condition);
3. Self-regulating activities (i.e., correction of
hypo and/or hyperglycemia).
This original tool consists of four factors: five
items in the first factor (nutrition specific and
weight), nine items in the second factor
(nutrition general and medical treatment),
three items in the third factor (physical
exercise), and three items in the fourth factor
(blood sugar). Two versions of the tool are
available, both of them consisting of these 20
items and differing mainly in the responses
available. The first one asks the respondent to
select from a five-point scale (yes definitely,
probably yes, maybe yes/maybe no, probably
no, definitely not) the answer that best suits
him/her to the question of how convinced he/
she is that he/she is able to perform the task
described in each item [20]. This version has
been translated and validated in Turkish [22]
and Iranian [23]. The second version uses an
11-point scale which ranges from 0 (cannot do
at all) to 10 (certainly can do) as response
options to the statement ‘‘I am confident that I
am able to…’’ which ends with each one of the
items included in the scale. This version has
been adapted for use in China [24] and Australia
[25]. In both occasions, response grades are
summed to produce a single score for
self-efficacy.
In accordance to European data, a 7%
prevalence of diabetes is reported for Greece
[3], but no tools measuring self-efficacy related
to diabetes self-management are available for
this population. Therefore, the aim of the
present study was to translate and culturally
adapt the DMSES into Greek (GR-DMSES) and to
test the psychometric properties of the
produced instrument in a Greek population of
middle-aged and elderly patients with T2D. This
validated version of DMSES will be used in the
ATTICA pilot of the EU-funded project
SmartCare, aiming to investigate whether
computer-based self-management support can
contribute to improve health outcomes of
patients with T2D aged over 50 years. Given
the need for a tool suitable for use in the
aforementioned study and the high prevalence
of T2D in older adults [26], the simplest
five-point answer scale [20] was chosen to be
translated and validated.
METHODS
To ensure the quality and the efficiency of the
adapted instrument in the Greek T2D
population, the validation of the GR-DMSES
was based on the procedure that has been
previously described in the literature [27]. This
procedure was accomplished in two phases.
First Phase: Translation, Cultural
Adaptation, and Content Validity
Measurement
Sample and Setting
A convenient sample of patients with T2D was
recruited from the Diabetic Association of
Piraeus and Islands in Attica, Greece, and from
a public, military hospital in the same area. In
total, 150 people were recruited and given a
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consent form. To determine the sufficient size
of the sample for factor analytic procedures, the
following two criteria were used: (1) the sample
should have 51 more cases than the number of
variables to support Chi-square testing in
Bartlett’s test of sphericity [28]; (2) the sample
should include at least 100 cases and a subjects
to variables (STV) ratio should be no less than 5
[29]. One of the authors (VE) collected all the
data through face-to-face interviews with the
participants, during a week. The information
collected was confidential and the study
procedures were according to the Declaration
of Helsinki of 1964, describing the Ethical
Principles for Medical Research Involving
Human Subjects, as revised in 2013.
Translation
Given the fact that there is no perfect method
for translating an instrument, multiple
techniques were used, as proposed for
cross-cultural research, namely forward
translation, consensus meeting, back
translation, and pre-test piloting [30, 31].
Forward translation: two bilingual (Greek and
English) translators worked independently to
produce a Greek version of the DMSES.
Consensus meeting: according to the WHO
Scientific Advisory Committee of the Medical
Outcomes Trust, the 8th requirement when
developing or translating an instrument is the
cultural adaption which also involves the
revision of the translated instrument by a
panel of experts [32]. To resolve any
ambiguities and discrepancies between the two
forward translated versions and to culturally
adapt the instrument, the items were revised
from a consensus group. The group consisted of
the two forward translators, a third bilingual
translator and one endocrinologist. Back
translation: the version produced by the group
was then back translated in English by two
bilingual translators whose mother tongue is
English and who had never before seen the
original English version of the scale.
Content Validity
To test content validity, the translated version
was sent to a panel consisting of eight experts in
the area of diabetes self-management, who were
familiarized with the conceptual underpinnings
and measurement model of the instrument.
This multidisciplinary team comprised three
endocrinologists, one diabetes specialist
pathologist, two registered dietitians, and two
registered nurses. Each of the health
professionals were asked to assess the necessity
of each item of the instrument through a
three-response Likert scale (1 = ‘‘necessary’’,
2 = ‘‘useful but not necessary’’, and
3 = ‘‘unnecessary’’). A content validity index of
individual items (I-CVI) was calculated for each
item as well as an overall score; average of the
I-CVIs for all items on the scale (S-CVI/Ave) for
the GR-DMSES. The I-CVI is computed as the
number of experts giving a rating of 1 (thus
dichotomizing the ordinal scale into necessary
and not necessary), divided by the total number
of experts. S-CVI/Ave is computed as the
average of the I-CVIs for all items on the scale.
According to Davis (1992), a content valid
instrument should have a minimum content
validity index of 0.80 [33]. During this
procedure, item 18 ‘‘I am able to visit my
doctor once a year to monitor my diabetes’’,
was changed to ‘‘I am able to visit my doctor
every three months to monitor my diabetes’’ to
reflect local best practice. Additionally, the
word ‘‘blood’’ from the phrase ‘‘blood sugar’’ in
items 1, 2, and 3, was not translated into Greek
at all, as it is not used in every day speaking
when someone is referring to blood sugar.
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Pre-test Piloting
The instrument was pilot tested with 10
patients with T2D from the Diabetic
Association of Piraeus and Islands in Attica,
Greece, to ensure that future users will
comprehend all questions and procedures [34].
Statement of doubts and suggestions regarding
each item of the scale was encouraged by
open-ended questions, asked by one of the
authors. No difficulties in understanding the
items were recorded. Completion of the
questionnaire took 6–12 minutes.
Second Phase: Psychometric Testing
Internal Consistency
To determine internal consistency, Cronbach’s
alpha was used, which is expressed as a number
between 0 and 1 [35]. Values that fall between
0.80 and 0.90 are considered a very good
indicator [36]. Except for overall alpha, two
other indicators are important for internal
consistency; corrected item–total correlation
and Cronbach’s alpha if item deleted. The first
indicator is a way to assess how well one item’s
score is internally consistent with composite
scores from all other items that remain. If this
correlation is weak (anything less than 0.30 is a
weak correlation for item-analysis purposes)
[37], then that item should be removed and
not used to form a composite score for the
variable in question. The other indicator is the
resulted Cronbach’s alpha if a given item is
deleted and it is valuable for determining which
of a set of items contributes to the total alpha.
Construct Validity
Construct validity was examined by
undertaking Principal-Component Factor
Analysis with a varimax rotation. To attain the
best fitting structure and the correct number of
factors, the following criteria were used: (1)
Kaiser rule, (2) the percentage of variation that
is explained, (3) scree plot. According to Kaiser
rule [38], the factors that should remain are
those with eigenvalue greater than 1.0, since
this essentially shows that this value is the
amount of variation explained by a factor and
the eigenvalue which is equal to 1.0 shows a
substantial change. A second selection method
based on similar conceptual structure is to
retain the number of factors that account for a
certain percent of variance extracted. There is
no unanimity in the literature regarding the
degree of the variance explained needed before
the number of factors is sufficient. The majority
suggest that 75–90% of the variance should be
accounted for [39]; however, some indicate that
as little as 50% of the variance explained is
acceptable [40], especially when the researcher’s
goal emphasizes parsimony (explaining
variance with as few factors as possible). The
third criterion is the Cattell’s scree plot, which
helps to determine the number of factors seeing
the breaking point or elbow [41]. Ultimately,
the decision regarding the number of factors to
retain should be made based on
comprehensibility and interpretability in the
context of the research [29].
Additionally, it is determined that only
factors with loadings[0.30 were included in
each factor. Prior to conducting factor analysis,
the following conditions were examined to
determine if it was appropriate to continue
with the specific analysis: correlation matrix,
communalities, reproduced correlations,
measures of sampling adequacy (MSA).
Kaiser–Meyer–Olkin measure of sampling
adequacy (KMO) and Bartlett’s test were
calculated to evaluate whether the sample was
large enough to perform a satisfactory factor
analysis. The KMO should be greater than 0.5 to
proceed with a satisfactory factor analysis and
values greater than 0.8 consist a really good
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indicator [38]. The P value of Bartlett’s test of
sphericity (which tests the null hypothesis that
the original correlation matrix is an identity
matrix) should be significant and lower than
0.05 [38].
Stability
For examining test–retest reliability and
stability, 25 participants, randomly selected
from the total sample, completed for the
second time the questionnaire 5 weeks after
the first completion. Based on a code that each
respondent had, the respondent’s data of the
first and second measurement could be detected
and matched. Then, by means of the intraclass
correlation coefficient (ICC), the test–retest
reliability was calculated, with appropriate
transformation of data.
Statistical Analysis
Data analysis was conducted using SPSS
statistical software version 21 (SPSS Inc.,
Chicago, IL, USA). All variables of the study
were calculated with descriptive analysis
including mean, standard deviation (SD),
frequency and percentage. The psychometric
properties of the GR-DMSES were determined
with item analysis, reliability, and validity. Item
analysis were conducted with item–total
correlations. To test the reliability of the
GR-DMSES, internal consistency using
Cronbach’s alpha for each subscale and the
overall DMSES. Construct validity was
examined by undertaking
Principal-Component Factor Analysis with a
varimax rotation. To test stability of the
GR-DMSES, test–retest reliability was evaluated
using ICC using a two-way random effects




From the 150 people initially recruited to
participate in the study, only 117 returned
completed questionnaires (response rate 78%)
and consent forms. One of the questionnaires
was excluded due to substantial missing data,
thus leaving 116 tools for analysis. This number
of participants produced an STV ratio of 5.8.
Demographic characteristics of the participants
are summarized in Table 1. The age of
participants ranged from 36 to 86 years with a
mean age of 64.4 years (SD = 10.42). The
research group was 41.8% male and 58.2%
female. Most of the patients had graduated
from high school (33.6%), 30.9% had secondary
school education, 25.5% elementary education
level, and 10% had university or other
education. The majority of patients were
married (66.7%), 8.8% were divorced, 6.1%
were unmarried, and 18.4% co-habited with
someone else. Most of the patients had public
insurance (90%), 6.4% had private, and 3.6%
had both. The average number of years
depicting diabetes duration was 12.9 years
(SD = 8.05) ranging from 1 to 38 years.
Content Validity
As it is already mentioned, the translated scale
was judged by an expert panel of eight
healthcare professionals on relevance and
phrasing of the instrument items. S-CVI/Ave
for GR-DMSES was computed and found to be
0.85.
Internal Consistency
The GR-DMSES had an overall coefficient alpha
of 0.93 (Table 2). The corrected item–total
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correlations indicated good correlations
(different from zero) for all the items. Removal
of one or more weakly correlated items did not
result in major consequences on the alpha
value. The mean corrected item–total
correlation for the GR-DMSES was 0.61
(minimum = 0.46, maximum = 0.74; Table 3).
Cronbach’s alpha coefficients, for each of the
subscales identified during construct validity
testing of GR-DMSES, were 0.92 for diet, 0.76 for
medical therapy, 0.70 for medication and feet
check, and 0.79 for physical activity.
Construct Validity
Regarding the criteria needed to be satisfied in
order to proceed with factor analysis, Bartlett’s
test of sphericity was found to be significant
(v2 = 1041.94, P\0.001) and the KMO measure
of sampling adequacy was found to be
acceptable (0.87). Based on the results of these
two tests and other conditions which were
satisfied (correlation matrix, communalities,
reproduced correlations, MSA), it was
determined that a factor analysis could be
computed on this data set.
The three criteria that were used in order to
obtain the best fitting structure and the correct
number of factors produced different number of
factors. Specifically, components with
eigenvalues greater than 1.0, produced five
factors, Cattell’s scree test plot, indicated four
factors (Fig. 1) and the percentage of total
variance explained by each factor, revealed at
least two factors (Table 4). Due to disagreement






















Yes, public 90.0 92.0
Yes, private 6.4 8.0
Yes, both 3.6 0.0
Age (years), mean ± SD 64.4 ± 10.42 64.1 ± 14.05
Disease duration (years),
mean ± SD
12.9 ± 8.05 11.0 ± 6.72
SD standard deviation






Diet (items 4, 5, 9, 10, 13,
14, 15, 16, 17)
9 0.92
Medical therapy (items 1, 2,
3, 6, 18)
5 0.76
Medication and feet check
(items 7, 19, 20)
3 0.70
Physical activity (items 8, 11,
12)
3 0.79
GR-DMSES Greek version of the Diabetes Management
Self-Efﬁcacy Scale
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of methods, four factors were decided to be the
optimum solution, based on comprehensibility
and interpretability in the context of the
research [29]. These four factors explained the
66.2% of the total sample variance.
The principal components that were chosen
follow the statement that the first component
accounts for the maximum part of the variance
which was 43.5% with eigenvalue 8.7 (Table 4).
This factor describes the nutritional
adjustments a diabetic person is recommended
to do in order to manage the disease. On this
factor, loadings are found for items which
concern the ability of the patient to follow
dietary recommendations when he/she is under
specific circumstances, such as being ill, away
from home, on holiday, at a party, or in a
specific psychological pressure like stress (items
4, 5, 9, 10, 13, 14, 15, 16, 17). The second
component explains the maximum part of the
remaining variance (9.8%) with an eigenvalue
of 2.0. On this factor, loadings are found about









DMSES1 40.48 230.419 0.458 0.928
DMSES2 40.33 227.771 0.591 0.926
DMSES3 40.46 228.846 0.602 0.926
DMSES4 40.09 226.658 0.613 0.925
DMSES5 40.04 224.749 0.647 0.925
DMSES6 39.91 226.134 0.517 0.927
DMSES7 40.28 224.467 0.580 0.926
DMSES8 39.85 222.417 0.572 0.926
DMSES9 40.22 223.080 0.732 0.923
DMSES10 40.24 225.444 0.708 0.924
DMSES11 40.05 225.188 0.590 0.926
DMSES12 40.12 223.296 0.639 0.925
DMSES13 39.72 220.848 0.649 0.924
DMSES14 39.80 221.019 0.677 0.924
DMSES15 39.86 217.242 0.745 0.922
DMSES16 39.76 223.182 0.627 0.925
DMSES17 39.40 221.171 0.618 0.925
DMSES18 40.25 229.879 0.473 0.928
DMSES19 40.76 231.849 0.584 0.926
DMSES20 40.41 229.031 0.562 0.926
Cronbach’s alpha = 0.929
DMSES Diabetes Management Self-Efﬁcacy Scale
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blood sugar control, weight control, and
visiting doctor regularly (items 1, 2, 3, 6, 18).
The third factor explains 7.4% of the variance
with an eigenvalue of 1.5 and has to do with the
medication and feet check, including taking
and adjusting medication and self-examination
of feet (items 7, 19, 20). The last factor explains
5.5% of the variance with an eigenvalue of 1.1.
This factor refers to items related to physical
activity and it includes three items concerning
the ability to take enough exercise, more
exercise if doctor suggests that and the ability
to adjust eating plan when taking more exercise
(items 8, 11, 12). Fourteen items had double
loading, but for the majority of them (9 items)
the bigger factor loading was kept (Table 5).
One item had almost equal factor loadings
(ability to adjust eating plan when ill) and in
this case the loading taken into account was
chosen based on better interpretation of the
analysis. The same applied for the remaining
four items, which the smaller factor loading was
taken into account for the same reason.
Stability
Twenty-two percent of the sample was
completed the scale for the second time after
5 weeks from initial approach. ICC was found to
be 0.87 (95% confidence interval 0.085–0.965,
P\0.001).
DISCUSSION
The objective of this study was to translate,
culturally adapt and evaluate the validity and
reliability of the DMSES among a Greek
population. According to the results of the
present study, the items were homogenous to
the scale; as the mean and variance scores of
each item and item–total correlation confirmed
this homogeneity.
The sample size in the present study was
larger than that of the Australian (n = 88) and
Turkish (n = 101) validation studies and smaller
than that of the Iranian (n = 332) and Chinese
(n = 230) validation studies [22–25]. For
sample size determination, all criteria that
were suggested in the methods section were
satisfied.
The content validity of this scale seems
sufficiently secured. Specifically, the S-CVI/Ave
score depicted acceptable agreement [42, 43], but
was found to be smaller than that calculated in
the validation study for the Chinese version
(0.86) [24]. In the present study, the expert panel
consisted of professionals working with diabetic
patients coming from different disciplinesFig. 1 Scree plot for determination of number of factors






1 8.701 43.503 43.503
2 1.961 9.806 53.309
3 1.474 7.370 60.680
4 1.108 5.541 66.221
a The latent dimension is taken to be equal to the number
of eigenvalues which are[1.0
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(nurses, dietitians, endocrinologists), all being
aware that self-efficacy consists a major
determinant of self-management. However,
there were no self-efficacy experts in the panel
as there is no such specialty in Greece.
Reliability of the GR-DMSES was high with a
value of 0.93 of the total scale and ranged from
0.70 to 0.92 for the subscales. This is similar to
findings reported for the Iranian (0.92), English
(0.91), and Chinese versions (0.93), and higher
Table 5 Rotated factor matrix of the Greek version of the Diabetes Management Self-Efﬁcacy Scale (n = 116)
Factor 1 Factor 2 Factor 3 Factor 4
Factor 1: diet
4. I am able to choose the correct food 0.566 0.455
5. I am able to choose different foods and stick to a healthy eating pattern 0.547 0.508
9. I am able to adjust my eating plan when ill 0.537 0.540
10. I am able to follow a healthy eating pattern most of the time 0.445 0.668
13. I am able to follow a healthy eating pattern when I am away from home 0.832
14. I am able to adjust my eating plan when I am away from home 0.826
15. I am able to follow a healthy eating pattern when I am on holiday 0.798 0.347
16. I am able to follow a healthy eating pattern when I am eating out or at a
party
0.768 0.387
17. I am able to adjust my eating plan when I am feeling stressed or anxious 0.684 0.324
Factor 2: medical therapy
1. I am able to check my blood sugar if necessary 0.651
2. I am able to correct my blood sugar when the sugar level is too high 0.358 0.576
3. I am able to correct my blood sugar when the blood sugar level is too low 0.496 0.620
6. I am able to keep my weight under control 0.414 0.333
18. I am able to visit my doctor every three months to monitor my diabetes 0.748
Factor 3: medication and feet check
7. I am able to examine my feet for cuts 0.736 0.357
19. I am able to take my medication as prescribed 0.663 0.512
20. I am able to adjust my medication when I am ill 0.662
Factor 4: physical activity
8. I am able to take enough exercise, for example, walking the dog or riding a
bicycle
0.302 0.802
11. I am able to take more exercise if the doctor advises me to do so 0.891
12. When taking more exercise I am able to adjust my eating plan 0.389 0.696
Variance explained (%) 43.5 9.8 7.4 5.5
Extraction method: Principal-Component Analysis, rotation method: varimax with Kaiser normalization
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than the Dutch (0.81) and Turkish versions
(0.88) [20, 22–25].
It is of note that the various versions differ
in the number of factors revealed. In the
present study, four factors were generated, in
concordance to the Chinese and Dutch tools
[20, 24], whereas in the Turkish version there
were three factors [22] and in the Iranian
version, five factors [23]. The difference in the
number of generated factors between the
present version and other versions, could be
related either to the various response scales of
the instruments or to different sample sizes.
The present tool is closer to the original
regarding sample size and uses the same
response scale, parameters that may explain
the fact that in both tools four factors were
revealed. Differences were also apparent
regarding the content of factors. Factor 1 in
GR-DMSES is the same to factor 1 of the
Chinese version and similar to the sum of
factors 1 and 2 of the Dutch version. Factor 2
in GR-DMSES is similar to factor 2 and two
items present in factors 3 and 4 of the Chinese
version, and to factor 4 plus two items present
in factors 1 and 2 of the Dutch version. Factor
3 is similar to factor 4 of the Chinese version
and there is no similarity with any of the
factors found in the Dutch version. Finally,
factor 4 is similar to factor 3 of the Chinese
version, which has an extra item and identical
to factor 3 of the Dutch version.
The findings with regard to stability of the
instrument, measured with a time interval of
5 weeks, can be judged as excellent good with
an ICC of 0.87. This finding on the test–retest
reliability indicated good stability of the
GR-DMSES according to Rosner’s
recommendation, who suggested that an
ICC [0.75 means excellent reproducibility
[44]. This finding is similar to that of the
Turkish version of DMSES where the ICC was
found to be 0.91. There are two common
methods to calculate test–retest reliability:
Pearson’s product-moment correlation and
ICC [45]. However, the Pearson’s
product-moment correlation, which is used
in other studies, has limitations such as an
inability to detect a systematic error [45]. On
the other hand, ICC has been reported to be
a more sensitive method to assess test–retest
reliability.
Nevertheless it should be noted that this
tool was validated in middle and old age urban
convenient population suffering from T2D.
This may limit the generalizability of the
findings in other age groups or rural
populations.
Summarizing, self-efficacy is a major
determinant of self-regulation and diabetes
consists a highly prevalent, among Greeks,
chronic disease demanding self-management.
Health professionals are in position to help
people with diabetes improve their self-efficacy.
However, the first step of nutrition care process,
a systematic approach to providing high-quality
nutrition care [46], is assessment. Having a
validated tool appropriate for the population
to assess self-efficacy is really important in the
realm of providing the best nutritional support.
Moreover, applying an already widely used tool
gives the opportunity to health professionals to
compare the effectiveness of their intervention,
regarding self-efficacy, to that of other studies
and further improve their techniques. This
study showed that GR-DMSES is a valid and
reliable scale and could be used to measure
self-efficacy related to diabetes
self-management of Greek diabetic patients,
thus providing a quick and easy-to-use tool to
health professionals dealing with Greek adults
with T2D.
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